JPH11189277A - Chemical liquid container to be prepared before using - Google Patents
Chemical liquid container to be prepared before usingInfo
- Publication number
- JPH11189277A JPH11189277A JP9358034A JP35803497A JPH11189277A JP H11189277 A JPH11189277 A JP H11189277A JP 9358034 A JP9358034 A JP 9358034A JP 35803497 A JP35803497 A JP 35803497A JP H11189277 A JPH11189277 A JP H11189277A
- Authority
- JP
- Japan
- Prior art keywords
- container
- communication member
- communication
- liquid
- container body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
- B65D81/3205—Separate rigid or semi-rigid containers joined to each other at their external surfaces
- B65D81/3211—Separate rigid or semi-rigid containers joined to each other at their external surfaces coaxially and provided with means facilitating admixture
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Package Specialized In Special Use (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は粉末剤、錠剤、顆粒
剤、液剤（たとえば、水溶液、懸濁剤、乳剤など）など
の第１薬剤を簡単な操作で液状の第２薬剤と混合して使
用するためのとくに点眼用、点耳用または点鼻用容器と
して好適な用時調製型薬液容器（以下、薬液容器とい
う）に関する。The present invention relates to a method of mixing a first drug such as a powder, tablet, granule, or liquid (eg, aqueous solution, suspension, emulsion, etc.) with a liquid second drug by a simple operation. The present invention relates to a ready-to-use drug solution container (hereinafter, referred to as a drug solution container) suitable as a container for eye drops, ear drops, or nasal drops for use.
【０００２】[0002]
【従来の技術】従来より、液状で保存すると変質したり
効力を失うなどの不具合が生じる粉末状または固形状の
薬剤は、使用直前に混合して用いられている。この種の
薬剤は、従来、溶解液と別の容器に収納され、使用時に
たとえば第三の容器に移し変え、これに溶解液を注入し
混合して使用したり、溶解液を注射器などに吸入しこれ
を薬剤容器に注入し混合して使用するのが一般的であ
る。しかしながら、第三の容器への移し変えや注射器を
使用しての操作は、手間がかかり、また、細菌の混入の
虞があるため衛生的にも問題があった。2. Description of the Related Art Conventionally, powdery or solid drugs that cause problems such as deterioration and loss of efficacy when stored in a liquid state have been used by being mixed immediately before use. Conventionally, this kind of drug is stored in a separate container from the dissolving solution, and is transferred to, for example, a third container at the time of use, and the dissolving solution is injected into this and mixed, or the dissolving solution is inhaled into a syringe or the like. In general, this is poured into a medicine container and mixed for use. However, the transfer to the third container and the operation using a syringe are troublesome, and there is a problem in hygiene because there is a risk of contamination by bacteria.
【０００３】そこで、このような問題を解決するものと
して、すでに、特表昭６１−５０１１２９号公報や特開
平２−１２７７号公報、特開平３−３７０６７号公報な
どに示されるような完全な無菌的溶解操作を目的とする
ものや、特開昭５９−２０９５３５号公報や特開昭６２
−１３７０５６号公報、特開平２−４３７５号公報、特
公平２−２６５０６号公報などに示される、完全な無菌
操作はできないが薬剤と溶解液の組合せを任意に選択す
ることのできる実質的に無菌的な操作を可能とするも
の、などが提案されている。[0003] To solve such a problem, a completely sterile system as disclosed in Japanese Patent Publication No. 61-501129, Japanese Patent Application Laid-Open No. 2-1277, Japanese Patent Application Laid-Open No. 3-37067, etc. has already been proposed. For the purpose of a manual dissolution operation, and those disclosed in JP-A-59-209535 and JP-A-62
No. 137056, JP-A-2-4375, JP-B-2-26506, etc., cannot be completely sterilized, but can substantially select a combination of a drug and a dissolving solution. A device that enables a simple operation has been proposed.
【０００４】特表昭６１−５０１１２９号に示されるも
のは、薬剤容器の収容されたカプセルと溶解液の収容さ
れた可撓性容器とがチューブで接続されたものであり、
チューブ内に設けられた連通手段によって薬剤容器と可
撓性容器が連通され、薬剤と溶解液とが無菌的に混合さ
れるようになっている。また、特開平２−１２７７号公
報に示されるものは、薬剤容器の収容されたカプセルを
その結合部で溶解液容器の口部と接続し、カプセルの結
合部側に連通順序規制手段を備えた連通手段を介在させ
たもので、連通手段により薬剤容器が刺通されたのちに
溶解液容器が刺通されて二つの容器が連通され、薬剤と
溶解液とが無菌的に混合されるようになっている。特開
平３−３７０６７号公報に示すものは、薬剤容器と連通
手段と溶解液容器をこの順序で配列して合成樹脂製シー
トで密封した上、薬剤容器と溶解液容器の間にシートの
上から容器支持手段を介在させたもので、無菌的な連通
・混合操作を行う時まで二つの容器が接近しないように
なっている。Japanese Patent Application Laid-Open No. 61-501129 discloses a capsule in which a capsule containing a drug container and a flexible container containing a solution are connected by a tube.
The communication container provided in the tube connects the medicine container and the flexible container, and the medicine and the solution are mixed aseptically. Japanese Patent Application Laid-Open No. 2-1277 discloses that a capsule containing a medicine container is connected to an opening of a solution container at a joint thereof, and a communication order regulating means is provided on the joint side of the capsule. With the communication means interposed, the solution container is pierced after the drug container is pierced by the communication means, the two containers are communicated, and the drug and the solution are aseptically mixed. Has become. Japanese Unexamined Patent Publication No. Hei 3-37067 discloses that a medicine container, a communicating means, and a solution container are arranged in this order, sealed with a synthetic resin sheet, and between the medicine container and the solution container from above the sheet. With the container supporting means interposed, the two containers do not approach each other until the aseptic communication / mixing operation is performed.
【０００５】一方、特開昭５９−２０９５３５号公報に
は、可撓性壁体部材を有する密封された第１の可撓性容
器と、この可撓性容器の壁体部材に貫通して固定でき、
取外しうるストッパーを有する第２の容器と、ストッパ
ーと噛み合う部分を有するストッパー取外し部材からな
り、第１の容器に第２の容器を貫通してストッパーをス
トッパー取外し部材と噛み合わせた後、第１の可撓性容
器の密封バリヤーと一緒にストッパーを第２の容器から
取外して二つの容器の内容物を混合できるようにした装
置が開示されており、特開昭６２−１３７０５６号公報
および特開平２−４３７５号公報に示されるものは、前
記第２の容器を改良したものである。また、特公平２−
２６５０６号公報に示すものは、特開昭５９−２０９５
３５号公報に開示された装置を改良したものである。On the other hand, JP-A-59-209535 discloses a sealed first flexible container having a flexible wall member, and a penetrating and fixing through the wall member of the flexible container. Can,
A second container having a removable stopper, and a stopper removal member having a portion that engages with the stopper. A device is disclosed in which a stopper is removed from a second container together with a sealing barrier of a flexible container so that the contents of the two containers can be mixed. Japanese Patent No. 4375 discloses an improved version of the second container. In addition,
No. 26506 is disclosed in JP-A-59-2095.
This is an improvement of the device disclosed in Japanese Patent Publication No. 35-35.
【０００６】前者の特表昭６１−５０１１２９号公報な
どに示される装置は、その構成上、薬剤容器と溶解液容
器とがペアーになっているため、調製される薬剤が一つ
に限定されてしまうという欠点を有しているものの、完
全な無菌操作を可能とするものであり、また、後者の特
開昭５９−２０９５３５号公報などに示される装置は、
完全な無菌操作はできないが、実質的に無菌的な操作が
可能であり、薬剤と溶解液の組合せを任意に選択するこ
とのできるものであるため、医療現場では必要に応じて
適宜両者の使い分けが必要になっている。[0006] In the former device disclosed in JP-T-61-501129 and the like, since the drug container and the dissolving solution container are paired due to its configuration, the drug to be prepared is limited to one. Although it has the drawback that it can be completely sterilized, the apparatus disclosed in JP-A-59-209535 and the like,
Although complete aseptic operation is not possible, practically aseptic operation is possible and the combination of drug and dissolution solution can be arbitrarily selected. Is needed.
【０００７】[0007]
【発明が解決しようとする課題】しかしながら、前記後
者の特開昭５９−２０９５３５号公報などに示される装
置は、機構が複雑であり、またストッパーが第１の容器
内に落とされるなど欠点も多い。本発明は、上記の様な
事情に鑑みてなされたもので、構造が簡単で、容易かつ
無菌的に混合操作を行うことのできる薬液容器を提供す
ることを目的とする。However, the device disclosed in Japanese Patent Application Laid-Open No. 59-209535 described above has a complicated mechanism and many disadvantages such as a stopper being dropped into the first container. . SUMMARY OF THE INVENTION The present invention has been made in view of the above-described circumstances, and has as its object to provide a chemical solution container having a simple structure and capable of easily and aseptically performing a mixing operation.
【０００８】[0008]
【課題を解決するための手段】本発明は、上記の課題を
解決するために、水不透過性かつガス不透過性のフィル
ムで閉鎖された連通口を有する容器本体とフィルム破断
手段を備えた薬剤容器を、容器本体の連通口を隔てて液
密に連結した構成を採用している。すなわち、本発明
は、天面に連通口を備え、該連通口が水不透過性かつガ
ス不透過性のフィルムで閉鎖されるとともに、該連通口
の外側に同心状に筒状部が立設されてなる容器本体と、
基端部に前記フィルムを破断する刃先を有し先端部に薬
液滴下口を有する両端の開口した中空の連通部材と、該
連通部材の薬液滴下口を閉鎖するキャップとからなり、
前記連通部材が、前記容器本体の筒状部に液密に保持さ
れるとともに、前記基端部が前記筒状部にスライド自在
に挿着されてなる薬液容器である。In order to solve the above-mentioned problems, the present invention comprises a container body having a communication port closed by a water-impermeable and gas-impermeable film, and a film breaking means. A configuration is adopted in which the drug containers are connected in a liquid-tight manner with the communication port of the container body interposed therebetween. That is, according to the present invention, a communication port is provided on the top surface, the communication port is closed with a water-impermeable and gas-impermeable film, and a cylindrical portion is provided concentrically outside the communication port. A container body made of
A hollow communication member having both ends opened with a cutting edge at the base end and having a cutting edge for breaking the film at the distal end, and a cap for closing the medicine drop lower opening of the communication member,
A chemical solution container in which the communication member is held in a liquid-tight manner in a cylindrical portion of the container body, and the base end is slidably inserted into the cylindrical portion.
【０００９】ここで、連通部材を容器本体の筒状部に液
密に保持させるためには、前記容器本体の筒状部と連通
部材の少なくとも基端部をチューブ状のシートで液密に
被覆してもよく、また、前記連通部材の基端部を容器本
体の筒状部に液密に挿着してもよい。前記連通部材の基
端部に、前記容器本体の筒状部に液密に接着するフラン
ジが設けられてなるのが好ましく、また、前記フランジ
にパッキンが設けられてなるのが好ましい。前記連通部
材には、薬液の残液を無くするために、刃先から前記チ
ューブ状シートによるシール端にかけてスリットが設け
られるのが好ましい。本発明の薬液容器は点眼用、点耳
用または点鼻用容器に好適である。Here, in order to hold the communicating member in the tubular part of the container body in a liquid-tight manner, at least the base part of the tubular part of the container body and the communicating member are covered with a tubular sheet in a liquid-tight manner. Alternatively, the base end of the communication member may be liquid-tightly inserted into the cylindrical portion of the container body. It is preferable that a flange is provided at the base end of the communication member so as to adhere to the cylindrical portion of the container body in a liquid-tight manner, and it is preferable that a packing is provided on the flange. The communication member is preferably provided with a slit from a cutting edge to a seal end of the tubular sheet in order to eliminate a residual liquid of the chemical solution. The drug solution container of the present invention is suitable for a container for eye drops, ear drops or nasal drops.
【００１０】[0010]
【発明の実施の形態】つぎに本発明の実施の形態につい
て図面に基づいて説明する。図１は本発明の一実施の形
態を示す縦断面図であり、図２は図１の断面と直交する
面における縦断面図、図３は図１に示す連通部材の拡大
底面図（刃先側から見た状態を示す）、図４は図１の薬
液容器において、連通部材を容器本体側にスライドさせ
て容器本体の第１薬剤収容室と第２薬剤収容室を連通し
た状態を示す図である。図１に示すように、本発明の薬
液容器は、水不透過性かつガス不透過性のフィルム１４
で閉鎖された連通口１３とこの連通口１３の外側に同心
状に設けられた筒状部１５を備えた容器本体１と、基端
部に刃先２１を有し先端部に薬液滴下口２２を有する中
空の連通部材２と、薬液滴下口２２を閉鎖するキャップ
３からなり、連通部材２は、容器本体１の筒状部１５に
液密かつスライド自在に保持されている。DESCRIPTION OF THE PREFERRED EMBODIMENTS Next, embodiments of the present invention will be described with reference to the drawings. FIG. 1 is a longitudinal sectional view showing an embodiment of the present invention, FIG. 2 is a longitudinal sectional view in a plane orthogonal to the section in FIG. 1, and FIG. 3 is an enlarged bottom view of the communicating member shown in FIG. FIG. 4 is a view showing a state in which the communication member is slid toward the container main body side to communicate the first medicine storage chamber and the second medicine storage chamber of the container main body in the liquid medicine container of FIG. is there. As shown in FIG. 1, the chemical container of the present invention comprises a water-impermeable and gas-impermeable film 14.
The container body 1 having a communication port 13 closed by the above and a cylindrical portion 15 provided concentrically outside the communication port 13, a cutting edge 21 having a cutting edge 21 at a base end and a drug droplet lower opening 22 at a tip end. It has a hollow communication member 2 and a cap 3 for closing the medicine droplet lower port 22. The communication member 2 is held by the tubular portion 15 of the container body 1 in a liquid-tight and slidable manner.
【００１１】容器本体１は一般にポリプロピレンやポリ
エチレン、ポリエステルなどの透明な可撓性合成樹脂で
形成された有底の容器で、天面１１と底面１２を有して
おり、天面１１には連通口１３が設けられ、天面１１の
表側には連通口１３の外側に同心状に筒状部１５が設け
られている。そして、この筒状部１５には連通部材２の
刃先２１を含む基端部が挿着され保持されており、連通
口１３は水分やガスを透過しないいわゆる水不透過性か
つガス不透過性のフィルム１４で閉鎖され、容器本体１
は天面１１とフィルム１４により筒状部１５側の第１薬
剤収容室１６と底面１２側の第２薬剤収容室１７に区画
されている。フィルム１４の形成材料としては、限定す
るものではないが、たとえば外層がポリエチレンテレフ
タレート（ＰＥＴ）フィルム、中間層がアルミフィルム
などのガスバリアー性フィルム、内層がポリエチレンや
ポリプロピレンを主成分とするポリオレフィン樹脂製フ
ィルムからなるラミネートフィルムなどが好適に採用さ
れる。前記第１薬剤収容室１６には、粉末剤、錠剤、顆
粒剤、液剤（たとえば、水溶液、懸濁剤、乳剤など）な
どの第１薬剤Ｄが収納され、前記第２薬剤収納室１７に
は、液状の第２薬剤Ｓが収納されている。The container main body 1 is a bottomed container generally formed of a transparent flexible synthetic resin such as polypropylene, polyethylene, or polyester, and has a top surface 11 and a bottom surface 12. An opening 13 is provided, and a cylindrical portion 15 is provided concentrically outside the communication port 13 on the front side of the top surface 11. A base end including the cutting edge 21 of the communication member 2 is inserted and held in the cylindrical portion 15, and the communication port 13 is a water-impermeable and gas-impermeable material that does not transmit moisture or gas. The container body 1 is closed with a film 14
Is partitioned by a top surface 11 and a film 14 into a first medicine storage chamber 16 on the cylindrical portion 15 side and a second medicine storage chamber 17 on the bottom surface 12 side. The material for forming the film 14 is not limited. For example, the outer layer is a polyethylene terephthalate (PET) film, the intermediate layer is a gas barrier film such as an aluminum film, and the inner layer is a polyolefin resin containing polyethylene or polypropylene as a main component. A laminated film made of a film is suitably employed. The first drug storage chamber 16 stores a first drug D such as a powder, a tablet, a granule, and a liquid (eg, an aqueous solution, a suspension, and an emulsion). , The liquid second medicine S is stored.
【００１２】連通部材２は一般にポリプロピレンやポリ
エチレン、ポリエステル、ＡＢＳ樹脂などの合成樹脂で
形成された両端の開口した中空な部材であり、基端部に
容器本体１のフィルム１４を破断する刃先２１を有し、
先端部に薬液滴下口２２を有している。連通部材２の基
端部は容器本体１の筒状部１５にスライド自在に挿着さ
れ液密に保持されており、その先端は刃先２１に形成さ
れ、刃先２１の付け根には筒状部１５の内径と略等しい
外径のフランジ２３が設けられている。このフランジ２
３は連通部材２を下方に移動させたときに、筒状部１５
内壁に沿って滑らかにスライドするようになっている。
一方、連通部材２の先端部の薬液滴下口２２はゴムやポ
リエチレンなどからなるキャップ３で閉鎖されている。
必要ならば先端部の外壁に雄ネジ２２１を設けてキャッ
プ３に設けた雌ネジ３２と螺合するようにしてもよい。
また、キャップ３には薬液滴下口２２の密封性をよくす
るために滴下口２２にフィットする突起３１を設けても
よい。The communication member 2 is generally a hollow member having both ends opened and formed of a synthetic resin such as polypropylene, polyethylene, polyester, or ABS resin, and has a cutting edge 21 for breaking the film 14 of the container body 1 at a base end. Have
It has a drug droplet lower port 22 at the tip. The base end of the communication member 2 is slidably inserted into the cylindrical portion 15 of the container body 1 and is held in a liquid-tight manner, and the distal end thereof is formed at the cutting edge 21. Is provided with a flange 23 having an outer diameter substantially equal to the inner diameter. This flange 2
When the communication member 2 is moved downward, the cylindrical portion 15
It slides smoothly along the inner wall.
On the other hand, the medicine droplet lower port 22 at the distal end of the communication member 2 is closed by a cap 3 made of rubber, polyethylene, or the like.
If necessary, a male screw 221 may be provided on the outer wall of the distal end portion and screwed with the female screw 32 provided on the cap 3.
Further, the cap 3 may be provided with a projection 31 that fits the dropping port 22 in order to improve the sealing performance of the drug droplet lower port 22.
【００１３】連通部材２の基板部を容器本体１の筒状部
１５に液密に保持するには、図１〜２に示すように、容
器本体１の筒状部１５と連通部材２の少なくとも基端部
をフィルム１４と同様の水不透過性かつガス不透過性の
フィルムからなるチューブ状のシート４で被覆し、この
チューブ状シート４の両端部分をそれぞれ筒状部１５外
壁および連通部材２の先端部に隣接する部分で接着する
ようにすればよい。また、図５〜６に示すように、フラ
ンジ２３の外径を筒状部１５の内径と同等に形成し、必
要ならばフランジ２３にパッキン２５を付け、パッキン
２５が筒状部１５の内壁と摺接するようにしてもよい。
なお、容器本体１の筒状部１５と連通部材２の少なくと
も基端部をチューブ状シート４で被覆した場合には、薬
液滴下時の残液を少なくするために、連通部材２の刃先
２１からチューブ状シート４によるシール端にかけてス
リット２４を設けるのが好ましい。In order to hold the substrate portion of the communication member 2 in a liquid-tight manner on the cylindrical portion 15 of the container main body 1, at least the cylindrical portion 15 of the container main body 1 and the communication member 2 as shown in FIGS. The base end is covered with a tubular sheet 4 made of a water-impermeable and gas-impermeable film similar to the film 14, and both end portions of the tubular sheet 4 are respectively provided on the outer wall of the tubular portion 15 and the communication member 2. May be bonded at a portion adjacent to the front end of the base. As shown in FIGS. 5 and 6, the outer diameter of the flange 23 is formed to be equal to the inner diameter of the tubular portion 15, and if necessary, a packing 25 is attached to the flange 23, and the packing 25 is attached to the inner wall of the tubular portion 15. It may be in sliding contact.
When the tubular portion 15 of the container body 1 and at least the base end of the communication member 2 are covered with the tubular sheet 4, the cutting edge 21 of the communication member 2 is removed from the cutting edge 21 in order to reduce the residual liquid when the drug droplets fall. It is preferable to provide the slit 24 over the seal end of the tubular sheet 4.
【００１４】つぎに本発明の薬液容器の使用について図
面を用いて説明する。図１に示すような薬液容器を用意
し、連通部材２を手などで上から押すと、連通部材２は
下方にスライドしてその先端の刃先２１で容器本体１の
連通口１３を塞いでいるフィルム１４を破断する。そし
て、このとき、第１薬剤収容室１６に収容されていた第
１薬剤が第２薬剤収容室１７に落ちるので、薬液容器を
よく震盪させて第１薬剤を第２薬剤と混合させれば薬液
を調製することができる（図４参照）。つぎに薬液滴下
口２２からキャップ３を外せば薬液を滴下することがで
きる。Next, the use of the chemical solution container of the present invention will be described with reference to the drawings. When the chemical liquid container as shown in FIG. 1 is prepared and the communication member 2 is pushed from above with a hand or the like, the communication member 2 slides downward and closes the communication port 13 of the container body 1 with the cutting edge 21 at the tip thereof. The film 14 is broken. Then, at this time, the first medicine contained in the first medicine accommodation chamber 16 falls into the second medicine accommodation chamber 17, so that the medicine container is shaken well to mix the first medicine with the second medicine. Can be prepared (see FIG. 4). Next, by removing the cap 3 from the drug droplet lower port 22, the drug solution can be dropped.
【００１５】[0015]
【発明の効果】以上説明してきたことから明らかなよう
に、本発明の薬液容器を採用することにより、極めて容
易かつ無菌的に第１薬剤と第２薬剤の混合操作を行うこ
とができる。また、構造が簡単なので、安価に薬液容器
を提供することができる。As is apparent from the above description, the use of the chemical liquid container of the present invention makes it possible to mix the first and second chemicals extremely easily and aseptically. In addition, since the structure is simple, a chemical solution container can be provided at low cost.
【図１】本発明の一実施の形態を示す縦断面図である。FIG. 1 is a longitudinal sectional view showing one embodiment of the present invention.
【図２】図１の断面と直交する面における縦断面図であ
る。FIG. 2 is a longitudinal sectional view in a plane orthogonal to the section in FIG.
【図３】図１に示す連通部材の拡大底面図（刃先側から
見た状態を示す）である。FIG. 3 is an enlarged bottom view of the communication member shown in FIG. 1 (showing a state viewed from the cutting edge side).
【図４】図１の薬液容器において、連通部材を容器本体
側にスライドさせて容器本体の第１薬剤収容室と第２薬
剤収容室を連通した状態を示す図である。FIG. 4 is a view showing a state in which the communication member is slid to the container body side to communicate the first medicine storage chamber and the second medicine storage chamber of the container body in the liquid medicine container of FIG. 1;
【図５】本発明の他の実施の形態を示す縦断面図であ
る。FIG. 5 is a longitudinal sectional view showing another embodiment of the present invention.
【図６】図５の薬液容器において、連通部材を容器本体
側にスライドさせて容器本体の第１薬剤収容室と第２薬
剤収容室を連通した状態を示す図である。FIG. 6 is a diagram showing a state in which the communication member is slid toward the container main body side to communicate the first medicine storage chamber and the second medicine storage chamber of the container main body in the liquid medicine container of FIG. 5;
１ 容器本体 ２ 連通部材 ３ キャップ ４ チューブ状シート １１ 天面 １２ 底面 １３ 連通口 １４ フィルム １５ 筒状部 １６ 第１薬剤収容室 １７ 第２薬剤収容室 ２１ 刃先 ２２ 薬剤滴下口 ２３ フランジ ２４ スリット ３１ 突起 ３２ 雌ネジ ２２１ 雄ネジ DESCRIPTION OF SYMBOLS 1 Container main body 2 Communication member 3 Cap 4 Tubular sheet 11 Top surface 12 Bottom surface 13 Communication port 14 Film 15 Cylindrical part 16 1st medicine accommodating chamber 17 2nd medicine accommodating chamber 21 Blade tip 22 Medicine dropping port 23 Flange 24 Slit 31 Projection 32 female screw 221 male screw
───────────────────────────────────────────────────── フロントページの続き (72)発明者 豆田 正和 大阪市北区本庄西三丁目９番３号 株式会 社ニッショー内 (72)発明者 長谷川 周司 大阪市北区本庄西三丁目９番３号 株式会 社ニッショー内 (72)発明者 大河原 貴光 大阪市北区本庄西三丁目９番３号 株式会 社ニッショー内 ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Masakazu Mameda 3-9-1, Honjo Nishi, Kita-ku, Osaka-shi Nissha Corporation (72) Inventor Shuji Hasegawa 3-9-1, Honjo-Nishi, Kita-ku, Osaka-shi Inside Nissha Corporation (72) Inventor Takamitsu Ogawara 3-9-3 Honjo Nishi, Kita-ku, Osaka City Inside Nissha Corporation
Claims (7)
過性かつガス不透過性のフィルムで閉鎖されるととも
に、該連通口の外側に同心状に筒状部が立設されてなる
容器本体と、基端部に前記フィルムを破断する刃先を有
し先端部に薬液滴下口を有する両端の開口した中空の連
通部材と、該連通部材の薬液滴下口を閉鎖するキャップ
とからなり、前記連通部材が、前記容器本体の筒状部に
液密に保持されるとともに、前記基端部が前記筒状部に
スライド自在に挿着されてなる用時調製型薬液容器。1. A communication port is provided on a top surface, the communication port is closed with a water-impermeable and gas-impermeable film, and a cylindrical portion is provided concentrically outside the communication port. A container body having a cutting edge at the base end thereof, a hollow communication member having both ends opened and having a cutting edge at the distal end, and a cap for closing the medicine droplet lower opening of the communication member. A time-adjustable liquid medicine container in which the communication member is held in a liquid-tight manner in the cylindrical portion of the container body, and the base end is slidably inserted in the cylindrical portion.
くとも基端部がチューブ状のシートで液密に被覆されて
なる請求項１記載の用時調製型薬液容器。2. The ready-to-use drug solution container according to claim 1, wherein at least a base end portion of the communication member with the tubular portion of the container body is liquid-tightly covered with a tubular sheet.
部に液密に挿着されてなる請求項１記載の用時調製型薬
液容器。3. The ready-to-use drug solution container according to claim 1, wherein a base end of the communication member is inserted in a liquid-tight manner into a tubular portion of the container body.
の筒状部に液密に接着するフランジが設けられてなる請
求項１、２または３記載の用時調製型薬液容器。4. The ready-to-use drug solution container according to claim 1, wherein a flange is provided at a base end of the communication member so as to be liquid-tightly adhered to a cylindrical portion of the container body.
る請求項４記載の用時調製型薬液容器。5. The ready-to-use drug solution container according to claim 4, wherein a packing is provided on the flange.
シートによるシール端にかけてスリットが設けられてな
る請求項２記載の用時調製型薬液容器。6. The ready-to-use drug solution container according to claim 2, wherein a slit is provided from a cutting edge of the communication member to a sealing end of the tubular sheet.
請求項１、２、３、４、５または６記載の用時調製型薬
液容器。7. The ready-to-use drug solution container according to claim 1, which is a container for eye drops, ear drops or nasal drops.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35803497A JP3840774B2 (en) | 1997-12-25 | 1997-12-25 | Preparation liquid container for use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35803497A JP3840774B2 (en) | 1997-12-25 | 1997-12-25 | Preparation liquid container for use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11189277A true JPH11189277A (en) | 1999-07-13 |
| JP3840774B2 JP3840774B2 (en) | 2006-11-01 |
Family
ID=18457203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP35803497A Expired - Fee Related JP3840774B2 (en) | 1997-12-25 | 1997-12-25 | Preparation liquid container for use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3840774B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002520093A (en) * | 1998-07-11 | 2002-07-09 | フレセニウス・アクチエンゲゼルシャフト | Sterile connectors for containers containing medical liquids |
| JP2004315067A (en) * | 2003-04-18 | 2004-11-11 | Dainippon Printing Co Ltd | Pouch and pouch with pouring port |
| JP2006167018A (en) * | 2004-12-14 | 2006-06-29 | Taisei Kako Co Ltd | Ophthalmic administration nozzle, ophthalmic administration container kit used by being dissolved before use and method thereof |
| JP2010516410A (en) * | 2007-01-25 | 2010-05-20 | ハイパーブランチ メディカル テクノロジー， インコーポレイテッド | Applicator and method of use for multi-component formulations |
| WO2012090486A1 (en) * | 2010-12-29 | 2012-07-05 | 東洋製罐株式会社 | Duplex container |
| JP2014076856A (en) * | 2012-09-21 | 2014-05-01 | Kirin Brewery Co Ltd | Two-chamber container, and mixing method of two liquids |
-
1997
- 1997-12-25 JP JP35803497A patent/JP3840774B2/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002520093A (en) * | 1998-07-11 | 2002-07-09 | フレセニウス・アクチエンゲゼルシャフト | Sterile connectors for containers containing medical liquids |
| JP2004315067A (en) * | 2003-04-18 | 2004-11-11 | Dainippon Printing Co Ltd | Pouch and pouch with pouring port |
| JP2006167018A (en) * | 2004-12-14 | 2006-06-29 | Taisei Kako Co Ltd | Ophthalmic administration nozzle, ophthalmic administration container kit used by being dissolved before use and method thereof |
| JP4608301B2 (en) * | 2004-12-14 | 2011-01-12 | 大成化工株式会社 | Dissolving eye dropper kit |
| JP2010516410A (en) * | 2007-01-25 | 2010-05-20 | ハイパーブランチ メディカル テクノロジー， インコーポレイテッド | Applicator and method of use for multi-component formulations |
| WO2012090486A1 (en) * | 2010-12-29 | 2012-07-05 | 東洋製罐株式会社 | Duplex container |
| JP2012140160A (en) * | 2010-12-29 | 2012-07-26 | Toyo Seikan Kaisha Ltd | Duplex container |
| CN103298710A (en) * | 2010-12-29 | 2013-09-11 | 东洋制罐集团控股株式会社 | Duplex container |
| CN103298710B (en) * | 2010-12-29 | 2015-03-04 | 东洋制罐集团控股株式会社 | Duplex container |
| JP2014076856A (en) * | 2012-09-21 | 2014-05-01 | Kirin Brewery Co Ltd | Two-chamber container, and mixing method of two liquids |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3840774B2 (en) | 2006-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210292073A1 (en) | Packaged products, inserts and compartments for aseptic mixing of substances, along with methods for use therewith | |
| EP0079326B1 (en) | Fluid transfer assembly | |
| US5380315A (en) | Mixing apparatus | |
| US6398031B1 (en) | Vial for packaging a liquid for medical use | |
| US5257986A (en) | Container for the separate sterile storage of at least two substances and for mixing said substances | |
| US6343717B1 (en) | Pre-filled disposable pipettes | |
| US4871354A (en) | Wet-dry bag with lyphozation vial | |
| KR100201014B1 (en) | Drug container and dual container system for fluid therapy employing the same | |
| JPH05103819A (en) | Medicine receiving container | |
| US4872872A (en) | Medicament container/dispenser assembly | |
| JPH11189277A (en) | Chemical liquid container to be prepared before using | |
| US20130269827A1 (en) | Two compartment syringe accessible package and method of using and making the same | |
| JPH1129180A (en) | Mixing container | |
| JP4822860B2 (en) | Medical multi-chamber container | |
| JPH07171192A (en) | Infusion vessel | |
| JPH10324374A (en) | Mixing container | |
| JPH11227844A (en) | Chemical liquid container for preparation as required | |
| JPH04221567A (en) | Medical container | |
| JPH11180476A (en) | Liquid medium container prepared before using | |
| JPH11198974A (en) | Liquid medicine container for preparing medicine when needed | |
| JP2005067726A (en) | Container for mixing and feeding small amount and multi-bag using this | |
| JPH0975425A (en) | Medical vessel | |
| JPH06343678A (en) | Vessel for infusion liquid | |
| JPH08332224A (en) | Syringe | |
| JP2000084047A (en) | Infusion solution container for two medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051031 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060411 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060510 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060602 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060510 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060718 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060731 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090818 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120818 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150818 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |